Greenleaf Peter
- SEC CIK
- 0001363683
In the past year, 2 open-market sale filings worth $37.5K and no purchases.
Current role at each company
- PTHS Pelthos Therapeutics Inc.Directoras of Jul 7, 2026
- AUPH Aurinia Pharmaceuticals Inc.Chief Executive Officeras of Mar 3, 2026
- ATRS Antares Pharma, Inc.Directoras of May 26, 2022
- BDSI Biodelivery Sciences International IncDirectoras of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $37.5K
- 2 filings
- Net
- −$37.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Greenleaf Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTHS Pelthos Therapeutics Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Greenleaf PeterDirector | SSale | −797 | $20.92 | −$16.7K | −3.1%24.7K after | 2 lots10b5-1 |
| Jul 7, 2026 (view filing)5:03 PM ET | Jul 2 | 5 days | Greenleaf PeterDirector | SSale | −797 | $26.13 | −$20.8K | −3.2%23.9K after | 2 lots10b5-1 |
AUPH Aurinia Pharmaceuticals Inc.
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Greenleaf PeterChief Executive Officer | SSale | −9.07K | $12.01 | −$108.9K | −21.6%33.0K after | |
| Feb 22, 2024 (view filing) | Mar 2, 2023 | 357 days | Greenleaf PeterChief Executive Officer | SSale | −33.0K | $8.78 | −$290.2K | −3.3%982.7K after | Amended |
| Mar 7, 2024 (view filing) | Mar 6 | 1 day | Greenleaf PeterChief Executive Officer | SSale | −127.0K | $5.60 | −$711.1K | −7.7%1.52M after | |
| Mar 4, 2025 (view filing) | Mar 3-4 | 1 day | Greenleaf PeterChief Executive Officer | SSale | −360.5K | $7.96 | −$2.87M | −16.8%1.79M after | 2 lots |